Eli Lilly
3,893 hedge funds and large institutions have $583B invested in Eli Lilly in 2025 Q3 according to their latest regulatory filings, with 215 funds opening new positions, 1,790 increasing their positions, 1,455 reducing their positions, and 162 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
8% less call options, than puts
Call options by funds: $12.7B | Put options by funds: $13.9B
1.82% less ownership
Funds ownership: 82.66% → 80.84% (-1.8%)
13% less funds holding in top 10
Funds holding in top 10: 291 → 253 (-38)
Holders
3,893
Holding in Top 10
253
Calls
$12.7B
Puts
$13.9B
Top Buyers
| 1 | +$3.22B | |
| 2 | +$1.26B | |
| 3 | +$858M | |
| 4 |
Amundi
Paris,
France
|
+$718M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$554M |
Top Sellers
| 1 | -$2.51B | |
| 2 | -$1.98B | |
| 3 | -$1.67B | |
| 4 |
Tiger Global Management
New York
|
-$1.18B |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.08B |